Soleno Therapeutics (SLNO) Other Non Operating Income (2013 - 2023)
Soleno Therapeutics (SLNO) posted quarterly Other Non Operating Income of $2.1 million for Q4 2023, up 1615.2% year-over-year from $125000.0 in Q4 2022, and up 1132.18% quarter-over-quarter from $174000.0 in Q3 2023.
Soleno Therapeutics (SLNO) Other Non Operating Income (2013 - 2023) Analysis & Trends
Soleno Therapeutics (SLNO) has reported Other Non Operating Income for 11 consecutive years, with $2.1 million the latest figure, recorded in Q4 2023.
- In Q4 2023, Other Non Operating Income rose 1615.2% year-over-year to $2.1 million; the TTM figure through Dec 2023 stood at $2.6 million (up 759.33% YoY), while the FY2023 annual figure was $2.6 million, up 759.33% from the prior year.
- Other Non Operating Income advanced to $2.1 million in Q4 2023 per SLNO's latest filing, from $174000.0 in the prior quarter.
- Across five years, Other Non Operating Income topped out at $2.1 million in Q4 2023 and bottomed at $1000.0 in Q2 2020.
- Historically, Other Non Operating Income has averaged $166052.6 across 5 years, with a median of $41000.0 in 2021.
- Annual changes were most pronounced in 2020 — Other Non Operating Income plunged 97.87% — and 2021, when it jumped 4000.0%.
- Soleno Therapeutics' Other Non Operating Income stood at $21000.0 in 2019, then slumped by 95.24% to $1000.0 in 2020, then soared by 3300.0% to $34000.0 in 2021, then soared by 267.65% to $125000.0 in 2022, then surged by 1615.2% to $2.1 million in 2023.
- Business Quant data shows SLNO's Other Non Operating Income at $2.1 million in Q4 2023, $174000.0 in Q3 2023, and $147000.0 in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Soleno Therapeutics | 2.74 Bn | 2.49 Bn | 93.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 2.14 Mn |
| Sep 30, 2023 | 174,000.00 |
| Jun 30, 2023 | 147,000.00 |
| Mar 31, 2023 | 113,000.00 |
| Dec 31, 2022 | 125,000.00 |
| Sep 30, 2022 | 101,000.00 |
| Jun 30, 2022 | 52,000.00 |
| Mar 31, 2022 | 22,000.00 |
| Dec 31, 2021 | 34,000.00 |
| Sep 30, 2021 | 34,000.00 |
| Jun 30, 2021 | 41,000.00 |
| Mar 31, 2021 | 1,000.00 |
| Sep 30, 2020 | 1,000.00 |
| Jun 30, 2020 | 1,000.00 |
| Mar 31, 2020 | 11,000.00 |
| Dec 31, 2019 | 21,000.00 |
| Sep 30, 2019 | 29,000.00 |
| Jun 30, 2019 | 47,000.00 |
| Mar 31, 2019 | 57,000.00 |
| Dec 31, 2018 | 29,000.00 |